SEC Company Response from AtriCure, Inc. (ATRC) (CIK 0001323885) (ATRC) — Aug 2, 2005
AtriCure, Inc. (ATRC) (CIK 0001323885)
Date: Aug. 2, 2005 · CIK: 0001323885 · Accession: 0001193125-05-155176
AI Filing Summary & Sentiment
File numbers found in text: 333-124197
Letter
Securities and Exchange Commission Washington, D.C. 20549 Re: AtriCure, Inc. Registration Statement on Form S-1 File No. 333-124197
Dear Ms. Fisher:
In connection with the above-captioned Registration Statement, the undersigned wish to advise that between July 19, 2005 and the date hereof, 6,322 copies of the Preliminary Prospectus dated July 19, 2005 were distributed as follows: 412 copies to underwriters and dealers; 2,241 copies to institutional investors; and 3,669 copies to individuals and others.
The undersigned advise that, and each underwriter and dealer has advised the undersigned that, we have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned hereby join in the request of AtriCure, Inc. that the effective date of the above-captioned Registration Statement be accelerated so that this Registration Statement may become effective by 2:00 p.m., New York time, on the 4th of August 2005 or as soon thereafter as practicable.
Signature page follows
Sincerely,
UBS SECURITIES LLC
Show Raw Text
CORRESP 1 filename1.htm Acceleration Letter UBS Securities LLC 299 Park Avenue New York, New York 10171 Piper Jaffray & Co. 800 Nicollet Mall Minneapolis, MN 55402 August 2, 2005 Ms. Peggy A. Fisher Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: AtriCure, Inc. Registration Statement on Form S-1 File No. 333-124197 Dear Ms. Fisher: In connection with the above-captioned Registration Statement, the undersigned wish to advise that between July 19, 2005 and the date hereof, 6,322 copies of the Preliminary Prospectus dated July 19, 2005 were distributed as follows: 412 copies to underwriters and dealers; 2,241 copies to institutional investors; and 3,669 copies to individuals and others. The undersigned advise that, and each underwriter and dealer has advised the undersigned that, we have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned hereby join in the request of AtriCure, Inc. that the effective date of the above-captioned Registration Statement be accelerated so that this Registration Statement may become effective by 2:00 p.m., New York time, on the 4th of August 2005 or as soon thereafter as practicable. Signature page follows Sincerely, UBS SECURITIES LLC PIPER JAFFRAY & CO. THOMAS WEISEL PARTNERS LLC A.G. EDWARDS & SONS, INC. By: UBS Securities LLC /s/ Tai Hah Name: Tai Hah Title: Managing Director /s/ Aradhana Sarin Name: Aradhana Sarin Title: Director By: Piper Jaffray & Co. /s/ Christie I. Christina Name: Christie I. Christina Title: Principal 2